Durable platelet response and immature platelet indices following sequential efgartigimod and eltrombopag therapy in a patient with refractory ITP.

Promacta (eltrombopag) - Novartis

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

http://www.ncbi.nlm.nih.gov/pubmed/42517215

Akifumi Takaori-Kondo; Fumiya Wada; Hiroyuki Matsui; Hisanori Umehara; Takuji Nakamura; Tomomi Satoh-Nakamura; Yutaka Shinkawa

Jul 29, 2026